1 Name. 1. (3 pts) What is apoptosis and how does it differ from necrosis? Which is more likely to trigger inflammation?
|
|
- Hector Dorsey
- 6 years ago
- Views:
Transcription
1 1 Name MCB 150 Midterm Eam #1 (100 points total) Please write your full name on each page of the eam!! The eam consists of 17 questions (6 pages). Each has a different point count as indicated. Please limit your answer to the space provided. 1. (3 pts) What is apoptosis and how does it differ from necrosis? Which is more likely to trigger inflammation? Apopsis:programmed cell death, tidy, material degraded by phagocytes/ necrosis: death from outside, messy, material released into etracelluar area promotes inflammation 2. (4 pts) What is a cytokine? Why do some viruses encode decoy cytokine receptors? Small secreted proteins mediates intercellular communication. Viruses use decoy receptor to block immune responses. 3. (5 pts) From a mouse s perspective, having a mutation in the TLR4 gene can be either a detriment or a benefit. Eplain. Detriment: susceptibility to bacterial infection Benefit: resistant to shock 4. (3 pts) What is the difference between a lymphoid organ and a secondary lymphoid organ? What is the main lymphoid organ in adults for B cells. Primary: where B cells and T cell develop/secondary where they respond to antigen /bone marrow is for B cells 5. (5 pts) How many antigen binding sites are found per molecule of: IgA 4 IgG 2 10 For an IgA and an IgG with the identical antigen binding site, which would bind more tightly to a multivalent ligand? Full credit given for all answers because of confusion during eam. For an IgA and an IgG with the identical antigen binding site, which would bind more tightly to a monovalent ligand? Full credit given for all answers because of confusion during eam.
2 2 Name 6. (7 pts) For each of the 5 major antibody isotypes indicate whether the following statements apply. IgG IgA IgE IgD Transported across epithelium into secretions () Eists in a membrane form only Triggers Mast cell degranulation () The earliest Ig secreted after infection Transported across the placenta Present at lowest concentration in blood Good at fiing complement () 0.5 pt for each missing or etra check / () means OK if they did or did not check it 7. (4 pts) For each of the following conditions indicate whether you would epect a precipitate to form? a.polyclonal antibody mied with a multivalent antigen b. Monoclonal antibody mied with a multivalent antigen c. Monoclonal antibody mied with a monovalent antigen d. Monoclonal antibody mied with a multivalent antigen in the presence of a large ecess of the same antigen in a monovalent form. Answer: a, b (not c, d) Full credit given for all answers because of confusion during eam. 8. (4 pts) You have isolated a viral protein (protein D) from a deadly virus and are testing this protein for its possible use as a vaccine against the virus. You first inject rabbits intravenously with purified protein D, then test for the effectiveness of your vaccination by eposing the treated rabbits to the deadly virus. You find that all the treated rabbits die. Provide two possible eplanations as to why your vaccine did not work and suggest two ways that you could improve it. Answer: Protein D may not be immunogenic enough to mount an immune response and thus you need to add an adjuvant (such as Freund s) with the vaccine strain to trigger the immune system. Additionally, subcutaneous administration is better then intravenous injection. (Also possible that you produced antibodies, but they were not protective) Other common answers I accepted: Protein D is similar to a rabbit protein so cells recognizing it had been deleted. Not enough time between the vaccine & eposure to the virus for an adaptive immune response to take place.
3 3 Name 9. (5 pts) Draw lines to match each receptor with its ligand: Receptors ligand TLR9 Constant region of Ig heavy chain TCR Ig TLR4 Fc receptor lipopolysacharide (LPS) bacterial DNA (CpG) peptide antigen-mhc soluble antigen 10. (4 pts) To the right is a diagram of an antibody molecule. Indicate on the diagram the location of: Antigen binding site Hinge region V H Ig domain Constant domain of light chain 11. (6 pts) You have three monoclonal antibodies directed against different epitopes of the same soluble, secreted protein antigen. Monoclonal A recognizes a conformational, surface epitope, and Monoclonal B recognizes a linear epitope that is only eposed when the protein is denatured and Monoclonal C recognizes a C-terminal linear, surface accessible epitope. For each technique listed below indicate which antibody/antibodies would be useful for detecting the antigen and briefly eplain why. Western blot B, C: linear epitopes maintained upon denaturation Flow cytometry None: antigen is secreted: wont be on cell surface. Sandwich ELISA A, C recognize epitopes eposed in soluble protein.
4 4 Name 12a. (4 pts) Above is a simplified map of the human germ-line light chain kappa locus. Indicate the positions of the following structures (if applicable): V segment D segment J segment C eon RSS 12b. (3 pts) Draw a diagram of the same locus after V(D)J rearrangement. Indicate the locations of the CDR1, CDR2 and CDR3 coding regions on the rearranged locus. 13. (5 pts) Eplain why an individual B cell can simultaneously produce and IgD, whereas a B cell epressing other isotypes (IgG, IgA, IgE) cannot epress. Alt mrna processing for /IgD CSR for other deletes locus. 14. (8 pts) You have identified a novel gene X in the mouse that is predicted to encode a member of the TLR family based on protein homology. You also have a potential ligand, y that is a component of the yeast cell wall that is know to trigger innate immunity but for which a corresponding TLR has not yet been identified. Describe how you would determine whether X induces innate immune responses to y. (You should mention the various methods you would use, and any essential controls, but you don t need to describe each method in great detail.) many possible answers including: Knock out gene X in a mouse using homologous recombination (X-/-). Epose X-/- and wild-type (wt, X) mouse to ligand y. Etract serum and test for production of cytokines using an ELISA assay. Isolate macrophages and dendritic cells and run flow cytometry to look for up-regulation of surface markers. If ligand y stimulates the novel TLR X, then you should see cytokine production and surface marker upregulation in the wt stimulated mouse but not in the X-/- mouse. As a positive control you can use other known TLR stimulants such as LPS which should induce cytokine production and upregulation of surface markers in both wt and X-/- mice.
5 5 Name 15. (12 pts) You discover a novel carbohydrate antigen (X) that is present on the red blood cells of a certain inbred mouse strain a, but not on the cells of another mouse strain b. Would you epect to find antibodies reactive to X in an a strain mouse? In a b strain mouse? Briefly eplain your answer. Not in a due to self tolerance Could be in b, if cross-reactive to a pathogen Briefly describe a procedure you might use to quantitate the presence of anti-x antibodies in mouse serum. Agglutination of RBC from B mouse Could use ELISA if have soluble form of X available In order to study B cell tolerance, you generate a transgenic mouse epressing HC and LC rearranged BCR transgenes that encodes an antibody reactive to X. Using a monoclonal antibody that is specific to the particular HC and LC combination of your transgene to detect the presence of the transgene encoded BCR, and an antibody that recognizes part of the Fc portion of, you perform flow cytometry of the spleen cells of transgenic mice and obtain the following results: Non transgenic Transgenic on a background Transgenic on b background Based on your flow cytometric analysis, what mechanism of B cell tolerance do you think is operating in this system? Briefly eplain how you know referring specifically to the cell populations in the above plots. Clonal deletion. + + cell are present in b but not a mice. In a perfect answer, would say that + B cells present in non tg, don t have specific BCR. In b background specific BCR epressing B cells present(upper rt quadrant), all B cells deleted in a background (no + or specific BCR+ cells present.) Draw a plot you might have seen if anergy were the mechanism of tolerance in this system. Transgenic on a background
6 6 Name 16. (8 pts) For each of the following phrases, say whether they are likely to apply to an initial () B cell response to a protein antigen, or to a B cell response generated after repeated immunizations with the protein antigen (secondary response), or to both. Requires T cell help. both Frequency of antigen specific B cells < 1/10000 Frequency of antigen specific B cells > 1/1000 secondary K d of antibodies < 10-6 M secondary K d of antibodies > 10-6 M High rate of somatic hypermutation secondary Very little somatic hypermutation Primarily produced 17. (10 pts) What is (are) each of the following and how are they important. (Two sentence limit for each): Allelic eclusion Mechanism that ensures that B cells only epress one of their HC and LC genes Hybridoma Hybrid between a myeloma cell and a plasma B cell: used to produce monoclonal antibody CD40 Receptor on B cell that binds to CD40L on helper T cell during T-B collaboration follicular dendritic cell cell that presents antigen to B cells in germinal center. Responsible for affinity maturation. λ5 component of surrogate light chain/prebcr that promotes pro > pre B cell transition and allelic eclusion.
In vitro cultures of bone marrow stromal cells and progenitor B cells can accurately recapitulate the normal steps of B cell development.
Regular Office Hours: Tuesdays 11-12 Extra office hours: Wed, Feb 7 12-1pm Thurs, Feb 8 11am-12 Fri, Feb 9 2-4pm I WILL NOT BE HOLDING OFFICE HOURS ON TUESDAY Feb 13!! Dina, Tim, and I encourage all confused
More informationB cell development The stages of B cell development
Regular Office Hours: Tuesdays 11-12 Extra office hours: Wed, Feb 7 12-1pm Thurs, Feb 8 11am-12 Fri, Feb 9 2-4pm I WILL NOT BE HOLDING OFFICE HOURS ON TUESDAY Feb 13!! Dina, Tim, and I encourage all confused
More informationProtein homology. Antigens & Antibodies I. Administrative issues:
Administrative issues: Recommended text: Goldsby/Kuby Immunology, 6th edition (Note that Innate Immunity is not adequately covered in the 5th edition.) Text book reading assignments are to supplement the
More informationAntibody Structure. Antibodies
Antibodies Secreted by B lymphocytes Great diversity and specificity: >10 9 different antibodies; can distinguish between very similar molecules Tag particles for clearance/destruction Protect against
More informationAntibody Structure supports Function
Antibodies Secreted by B lymphocytes Great diversity and specificity: >10 9 different antibodies; can distinguish between very similar molecules Tag particles for clearance/destruction Protect against
More informationBasic Antibody Structure. Multiple myeloma = cancerous plasma cells Monomer = 150,000. Chapter 4. Immunoglobulin Structure and Function
Chapter 4. Immunoglobulin Structure and Function. Functional Regions. Types of chains. Constant & Variable regions 4. Glycoprotein * * * Heavy chain= 446 aa Light chain= 4aa Each heavy and light chain
More informationGENETIC BASIS OF ANTIBODY STRUCTURE AND DIVERSITY. Steven J. Norris, Ph.D
GENETIC BASIS OF ANTIBODY STRUCTURE AND DIVERSITY Steven J. Norris, Ph.D Topics I. General principles II. The heavy chain Ig locus and VDJ rearrangement III. Light chain rearrangement. IV. Mechanisms of
More informationImmunological Techniques
Midterm Extra Office Hours Take Regular Office Hours: Tuesdays 11-12 Extra office hours: Wed, Feb 7 12-1pm Thurs, Feb 8 11am-12 Fri, Feb 9 2-4pm I WILL NOT BE HOLDING OFFICE HOURS ON TUESDAY Feb 13!! Dina,
More informationChapter 17: Immunization & Immune Testing. 1. Immunization 2. Diagnostic Immunology
Chapter 17: Immunization & Immune Testing 1. Immunization 2. Diagnostic Immunology 1. Immunization Chapter Reading pp. 505-511 What is Immunization? A method of inducing artificial immunity by exposing
More informationLECTURE: 22 IMMUNOGLOBULIN DIVERSITIES LEARNING OBJECTIVES: The student should be able to:
LECTURE: 22 Title IMMUNOGLOBULIN DIVERSITIES LEARNING OBJECTIVES: The student should be able to: Identify the chromosome that contains the gene segments that encode the surface immunoglobulin heavy chain
More informationCHAPTER 7 CELLULAR BASIS OF ANTIBODY DIVERSITY: CLONAL SELECTION
CHAPTER 7 CELLULAR BASIS OF ANTIBODY DIVERSITY: CLONAL SELECTION The specificity of humoral immune responses relies on the huge DIVERSITY of antigen combining sites present in antibodies, diversity which
More informationIMMUNOGLOBULIN GENES UNDERGO TWO DNA REARRANGEMENTS
A Prototype Ig Gene: Murine Kappa About 10 0 V κ gene segments 4 J Gene Segment s 1 C κ Gene Segmen t Multiple V gene segments, distant from J and C A few J gene segments One C gene segment GERMLINE Ig
More informationImmunoglobulins: Structure and Function
Immunoglobulins: Structure and Function Immunoglobulins:Structure and Function Definition: Glycoprotein molecules that are produced by plasma cells in response to an immunogen and which function as antibodies
More informationHigher National Unit specification General information Unit title: Unit code: Superclass: Publication date: Source: Version: Unit purpose Outcomes
Higher National Unit specification General information Unit code: H92E 35 Superclass: RH Publication date: May 2015 Source: Scottish Qualifications Authority Version: 02 Unit purpose This Unit is designed
More informationImmunology: Antibody Basics
e-learning JABSOM Immunology: Antibody Basics One :: General Structure Identify the Parts of an Antibody Two :: Isotypes Identify Antibody Isotypes Three :: Function Match Antibody Functions With Isotypes
More informationImmunoglobulins Harry W Schroeder Jr MD PhD
Immunoglobulins Harry W Schroeder Jr MD PhD Division of Developmental and Clinical Immunology Departments of Medicine, Microbiology, and Genetics University of Alabama at Birmingham Immunoglobulin Has
More informationSerology as a Diagnostic Technique
Serology as a Diagnostic Technique Characteristics of Any Diagnostic Techniques Any useful detection strategy must be: Specific: yield a positive response for only the target organism or molecule. Sensitive:
More informationImmunoglobulins. Biological Properties
Immunoglobulins Biological Properties Introduction Many important biological properties are attributed to antibodies that differ depending on isotype These include; - Neutralization of toxins - Immobilization
More informationPractical Applications of Immunology (Chapter 18) Lecture Materials for Amy Warenda Czura, Ph.D. Suffolk County Community College Eastern Campus
Practical Applications of Immunology (Chapter 18) Lecture Materials for Amy Warenda Czura, Ph.D. Suffolk County Community College Eastern Campus Primary Source for figures and content: Tortora, G.J. Microbiology
More informationCustom Antibodies Services. GeneCust Europe. GeneCust Europe
GeneCust Europe Laboratoire de Biotechnologie du Luxembourg S.A. 2 route de Remich L-5690 Ellange Luxembourg Tél. : +352 27620411 Fax : +352 27620412 Email : info@genecust.com Web : www.genecust.com Custom
More informationImmunological Techniques in Research and Clinical Medicine. Philip L. Cohen, M.D. Chief of Rheumatology, LKSOM 10 March 2016
Immunological Techniques in Research and Clinical Medicine Philip L. Cohen, M.D. Chief of Rheumatology, LKSOM 10 March 2016 Antibodies Remarkable Tools for Research and Diagnosis You can make an antibody
More informationDiscovery and Humanization of Novel High Affinity Neutralizing Monoclonal Antibodies to Human IL-17A
Discovery and Humanization of Novel High Affinity Neutralizing Monoclonal Antibodies to Human IL-17A Contacts: Marty Simonetti martysimonetti@gmail.com Kirby Alton kirby.alton@abeomecorp.com Rick Shimkets
More informationOmniAb. Naturally optimized human antibodies
OmniAb Naturally optimized human antibodies Transgenic animals for hmab discovery Only company to offer three platforms Patented technology with freedom to operate V L V H C C H 1 hinge C H 2 C H 3 2 28
More informationChapter 2. Antibodies
Chapter 2. Antibodies An iddy-biddy antibody Just nanometers long Saved the butt of a sumo man Hundreds of kilos strong Anonymous The main elements of the immune system are firstly antibodies, secondly
More informationCHAPTER 3 ANTIBODY STRUCTURE I
CHAPTER 3 ANTIBODY STRUCTURE I See APPENDIX: (3) OUCHTERLONY ANALYSIS; (6), EQUILIBRIUM DIALYSIS; (7) CROSS-REACTIVITY Electrophoretic separation of serum proteins identifies the GAMMA-GLOBULIN fraction
More informationStrategies for Assessment of Immunotoxicology in Preclinical Drug Development
Strategies for Assessment of Immunotoxicology in Preclinical Drug Development Rebecca Brunette, PhD Scientist, Analytical Biology SNBL USA Preclinical Immunotoxicology The study of evaluating adverse effects
More informationT and B cell gene rearrangement October 17, Ram Savan
T and B cell gene rearrangement October 17, 2016 Ram Savan savanram@uw.edu 441 Lecture #9 Slide 1 of 28 Three lectures on antigen receptors Part 1 (Last Friday): Structural features of the BCR and TCR
More informationSPECIFICITY, DIVERSITY, AND IMMUNOGLOBULIN GENES
SPECIFICITY, DIVERSITY, AND IMMUNOGLOBULIN GENES ANTIBODY SPECIFICITY. This can be thought of in terms of the goodness of fit (affinity) between an antigenic determinant and a lymphocyte receptor or antibody.
More informationAtlas of Genetics and Cytogenetics in Oncology and Haematology. IMMUNOGLOBULIN GENES: CONCEPT OF DNA REARRANGEMENT * Introduction
Atlas of Genetics and Cytogenetics in Oncology and Haematology IMMUNOGLOBULIN GENES: CONCEPT OF DNA REARRANGEMENT * Introduction I Historical questions II Answers II.1 Light chains (kappa or lambda) II.1.1
More informationApplication of Biacore Technology
Principles and typical results Application of Biacore Technology Common types of Biacore analyses Specificity analysis Is my molecule of interest specific for its target? Multiple binding analysis In which
More informationMOLECULAR RECOGNITION
MOLECULAR RECOGNITION Bioanalytical Methods Classification 1. Biassay: molecular recognition, signal generation and detection in solution or on inert solid phase 2. Biosensor: molecular recognition system
More informationAntibodies and Antigens in the Blood Bank 9/7/2015 NAHLA BAKHAMIS 1
Antibodies and Antigens in the Blood Bank NAHLA BAKHAMIS 9/7/2015 NAHLA BAKHAMIS 1 Outline Antibodies structure, classes and functions Most important Abs in the blood bank effective roles of Abs Zeta potential
More informationAntigen-Antibody Interaction
- Interaction JASON BROWNLEE Technical Report 070427A Complex Intelligent Systems Laboratory, Centre for Information Technology Research, Faculty of Information and Communication Technologies, Swinburne
More informationLecture 3. Used anti B cell marker antibodies to deplete in mice
Lecture 3 V-Gene Rearrangement and Expression Used anti B cell marker antibodies to deplete in mice Rat anti mouse CD19, anti mouse B220, and anti mouse CD22. Mice were then injected with a secondary antibody
More informationAntibodies and Antigens In the blood bank
Antibodies and Antigens In the blood bank 1 Nice game!! http://nobelprize.org/ 2 Karl Landsteiner discovered blood groups in 1901. Awarded Nobel Prize for Physiology or Medicine in 1930 3 Why we study
More informationبسم هللا الرحمن الرحيم. Today we're going to talk about the generation of diversity of the receptors of the lymphocytes
بسم هللا الرحمن الرحيم Today we're going to talk about the generation of diversity of the receptors of the lymphocytes The receptors of lymphocytes are : 1. B cells : immunoglobulins ; which are cell bound
More informationMake High Quality Affordable
Protein Antibody Gene Kit Cell Lysate Fc receptor Antibody Cancer antigen ed NK-Cell le as Cancer-Cell Perfo r i n a n d G r a n zy r me e Make Quality Affordable Fc receptor Function and s Function:,
More informationMEDICAL IMMUNOLOGY 544. Dr. George A. Gutman
I M M U N O L O G Y CORE NOTES MEDICAL IMMUNOLOGY 544 FALL 2011 Dr. George A. Gutman SCHOOL OF MEDICINE UNIVERSITY OF CALIFORNIA, IRVINE (Copyright) 2011 Regents of the University of California TABLE OF
More informationThe World Leader in SPR Technology. Jimmy Page, PhD, Biacore, Inc.
The World Leader in SPR Technology Jimmy Page, PhD, Biacore, Inc. Objectives of Biacore Experiments Yes/No Data» Is there binding?» Ligand Fishing Concentration Analysis: How MUCH? Active Concentration
More informationMake Your Immunology Research Easy. Kun YIN Associate Director of Marketing Division, GenScript
Make Your Immunology Research Easy Kun YIN Associate Director of Marketing Division, GenScript GenScript Overview Branch Office Amsterdam, Netherlands Branch Office Tokyo, Japan Headquarter, New Jersey,
More informationImmunogenicity of Therapeutic Fusion proteins: Contributory Factors and Clinical Experience
University of Rhode Island DigitalCommons@URI Institute for Immunology and Informatics Faculty Publications Institute for Immunology and Informatics (icubed) 2013 Immunogenicity of Therapeutic Fusion proteins:
More informationThe Biotechnology Education Company. Quantitative ELISA. Storage: See Page 3 for specific storage instructions EXPERIMENT OBJECTIVE:
The Biotechnology Education Company Revised and Updated Quantitative ELISA Storage: See Page 3 for specific storage instructions EXPERIMENT OBJECTIVE: EDVO-Kit # 278 The objective of this experiment is
More informationBiomolecular chemistry. 7. Antibodies: structure and function
154 Biomolecular chemistry 7. Antibodies: structure and function Suggested reading: Sections 5.1 to 5.3 of Mikkelsen and Cortón, Bioanalytical Chemistry Primary Source Material Biochemistry Chapter 33:
More informationAssays and Strategies for Immunogenicity Assessment. Steven J Swanson, Ph.D. Executive Director, Medical Sciences Clinical Immunology, Amgen
Assays and Strategies for Immunogenicity Assessment Steven J Swanson, Ph.D. Executive Director, Medical Sciences Clinical Immunology, Amgen General Antibody Assay Strategy Correlation of clinical findings
More informationGuideline on immunogenicity assessment of monoclonal antibodies intended for in vivo clinical use.
1 2 3 18 November 2010 EMA/CHMP/BMWP/86289/2010 Committee for Medicinal Products for Human Use (CHMP) 4 5 6 Guideline on immunogenicity assessment of monoclonal antibodies intended for in vivo clinical
More informationCOMMITTEE FOR VETERINARY MEDICINAL PRODUCTS NOTE FOR GUIDANCE 1 : DNA VACCINES NON-AMPLIFIABLE IN EUKARYOTIC CELLS FOR VETERINARY USE
The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Veterinary Use CVMP/IWP/07/98-FINAL COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS NOTE FOR GUIDANCE 1 : DNA VACCINES
More informationBIOTECHNOLOGY. Course Syllabus. Section A: Engineering Mathematics. Subject Code: BT. Course Structure. Engineering Mathematics. General Biotechnology
BIOTECHNOLOGY Subject Code: BT Course Structure Sections/Units Section A Section B Unit 1 Unit 2 Unit 3 Unit 4 Unit 5 Unit 6 Unit 7 Section C Section D Section E Topics Engineering Mathematics General
More informationCopyright Nikita S. Kolhatkar
Copyright 2015 Nikita S. Kolhatkar The Role of Altered Antigen Receptor Signaling in Selection and Homeostasis of Peripheral B cells in Wiskott-Aldrich Syndrome Nikita S. Kolhatkar A dissertation submitted
More informationSupplementary Figure 1
Supplementary Figure 1 Ex2 promotor region Cre IRES cherry pa Ex4 Ex5 Ex1 untranslated Ex3 Ex5 untranslated EYFP pa Rosa26 STOP loxp loxp Cre recombinase EYFP pa Rosa26 loxp 1 kb Interleukin-9 fate reporter
More informationLecture 25 (11/15/17)
Lecture 25 (11/15/17) Reading: Ch9; 328-332 Ch25; 990-995, 1005-1012 Problems: Ch9 (study-guide: applying); 1,2 Ch9 (study-guide: facts); 7,8 Ch25 (text); 1-3,5-7,9,10,13-15 Ch25 (study-guide: applying);
More informationRecombinant Antibody Production in Therapeutic Antibody Projects. Keshav Vasanthavada Senior Marketing Specialist, GenScript April 7, 2016
Recombinant Antibody Production in Therapeutic Antibody Projects Keshav Vasanthavada Senior Marketing Specialist, GenScript April 7, 2016 Presentation Outline 1 2 3 4 5 Introduction Recombinant Ab Production
More informationBiosensor technology and its application in aquaculture. Srinakharinwirot University
Biosensor technology and its application in aquaculture Assoc. Prof. Parin Chaivisuthangkura, i PhD Ph.D. Dept. of Biology, Faculty of Science Srinakharinwirot University Outlines Overview about monoclonal
More informationA Level. A Level Biology. DNA Technology Questions. AQA, OCR, Edexcel. Name: Total Marks: Page 1
AQA, OCR, Edexcel A Level A Level Biology DNA Technology Questions Name: Total Marks: Page 1 Q1.(a) (i) A mutation of a tumour suppressor gene can result in the formation of a tumour. Explain how.........(2)
More information1 R01 AI VMD HALFORD, W
1 R01 AI104935-01 2 VMD 1R01AI104935-01 ILLIAM CRITIQUE 1: Significance: 5 Investigator(s): 2 Innovation: 5 Approach: 8 Environment: 2 Overall Impact: This application proposes to develop a recombinant
More informationImmunology- Mic : First observed by Gruber and Durham when serum antibody was found to react with bacterial cells.
Immunology- Mic 451 Lab -Notes 1. Agglutination is the aggregation of particulate matter caused by the combination with specific antibody 1896: First observed by Gruber and Durham when serum antibody was
More informationNature Immunology: doi: /ni Supplementary Figure 1. Zranb1 gene targeting.
Supplementary Figure 1 Zranb1 gene targeting. (a) Schematic picture of Zranb1 gene targeting using an FRT-LoxP vector, showing the first 6 exons of Zranb1 gene (exons 7-9 are not shown). Targeted mice
More informationImmunology, Microbiology and Biotechnology
Biyani's Think Tank Concept based notes Immunology, Microbiology and Biotechnology (B.Sc. Part-II) Naresh Kumar Nirmal Revised By: Priyanka Khan Deptt. of Science Biyani Girls College, Jaipur 2 Published
More informationCytomics in Action: Cytokine Network Cytometry
Cytomics in Action: Cytokine Network Cytometry Jonni S. Moore, Ph.D. Director, Clinical and Research Flow Cytometry and PathBioResource Associate Professor of Pathology & Laboratory Medicine University
More informationAssays for Immunogenicity: Are We There Yet?
Assays for Immunogenicity: Are We There Yet? Mark Wener, MD Department of Laboratory Medicine & Rheumatology Division Department of Medicine University of Washington Seattle, WA 98195 wener@uw.edu Goals:
More informationCHAPTER 5 COMPLEMENT
CHAPTER 5 COMPLEMENT See APPENDIX (8) COMPLEMENT FIXATION ASSAY The complex of serum proteins known as COMPLEMENT plays key roles in the lytic and inflammatory properties of antibodies. The CLASSICAL pathway
More informationGenetics - Problem Drill 19: Dissection of Gene Function: Mutational Analysis of Model Organisms
Genetics - Problem Drill 19: Dissection of Gene Function: Mutational Analysis of Model Organisms No. 1 of 10 1. The mouse gene knockout is based on. (A) Homologous recombination (B) Site-specific recombination
More informationElevated Immunoglobulins and Paraproteins
Elevated Immunoglobulins and Paraproteins NWL Pathology GP Study Afternoon Thursday 19 th October 2017 Dr Aristeidis Chaidos Consultant Haematologist and Honorary Senior Clinical Lecturer Hammersmith Hospital,
More informationSPHERO TM Coated Particles
SPHERO TM Coated Particles Manufactured by either passive adsorption or covalent coupling depending upon the intended application Stable for several years under proper storage condition Available in a
More informationApplied Protein Services
Applied Protein Services Applied Protein Services A Window into the Future Development risk and attrition rates remain two of the greatest challenges to a successful biopharmaceutical pipeline. To help
More informationSynAbs S.A. Driving mab innovation for the IVD & BioPharma R&D markets
SynAbs S.A. Driving mab innovation for the IVD & BioPharma R&D markets February 20, 2016 SynAbs in a nutshell (1/2) Rat monoclonal antibodies, service and catalog Innovative guinea pig monoclonals! Mouse
More informationB cell Epitopes CENTER FOR BIOLOGICAL SEQUENCE ANALYSIS. Technical University of Denmark - DTU Department of systems biology
B cell Epitopes Antibody Effect Virus or Toxin Antibodies Antibody Effect Virus or Toxin Antibodies Antibodies Antibodies Antibody - Antigen interaction Antigen Antibody Antibody - Antigen interaction
More informationIntroducing new DNA into the genome requires cloning the donor sequence, delivery of the cloned DNA into the cell, and integration into the genome.
Key Terms Chapter 32: Genetic Engineering Cloning describes propagation of a DNA sequence by incorporating it into a hybrid construct that can be replicated in a host cell. A cloning vector is a plasmid
More informationFor the quantitative detection of human IL6 in serum, plasma, cell culture supernatants and urine.
m andw da a For the quantitative detection of human IL6 in serum, plasma, cell culture supernatants and urine. general information Catalogue Number Product Name Species cross-reactivity Range (calibration
More informationAmerican Association of Immunology Heidi Anderson: Lesson Plan for Cell Signaling and Immune System
B cell Modeling of Cell Communication and Signal Transduction Pathways: How can students visualize cellular discussions? Heidi M. Anderson 1 and Dr. Subbarao Bondada 2 1 Paul Laurence Dunbar High School,
More informationChapter 9 Genetic Engineering
Chapter 9 Genetic Engineering Biotechnology: use of microbes to make a protein product Recombinant DNA Technology: Insertion or modification of genes to produce desired proteins Genetic engineering: manipulation
More informationContents... vii. List of Figures... xii. List of Tables... xiv. Abbreviatons... xv. Summary... xvii. 1. Introduction In vitro evolution...
vii Contents Contents... vii List of Figures... xii List of Tables... xiv Abbreviatons... xv Summary... xvii 1. Introduction...1 1.1 In vitro evolution... 1 1.2 Phage Display Technology... 3 1.3 Cell surface
More informationUNIVERSITY OF CAMBRIDGE INTERNATIONAL EXAMINATIONS General Certificate of Education Advanced Level
UNIVERSITY OF CAMBRIDGE INTERNATIONAL EXAMINATIONS General Certificate of Education Advanced Level *1053462426* BIOLOGY 9700/43 Paper 4 Structured Questions A2 October/November 2010 2 hours Candidates
More informationHSV-2 therapeutic vaccine program. Subunit vaccine candidates
HSV-2 therapeutic vaccine program Subunit vaccine candidates Our HSV-2 vaccine program Therapeutic subunit vaccine T-cell-based Aim: Best-in-class antigens by engineering Excellent standing (Sept 2017):
More informationQImaging Camera Application Notes Multicolor Immunofluorescence Imaging
QImaging Camera Application Notes Multicolor Immunofluorescence Imaging In order to image localization of intracellular proteins with high specificity, it is frequently necessary to multiplex antibody
More informationReal-time PCR. Total RNA was isolated from purified splenic or LP macrophages using
Supplementary Methods Real-time PCR. Total RNA was isolated from purified splenic or LP macrophages using the Qiagen RNeasy Mini Kit, according to the manufacturer s protocol with on-column DNase digestion
More informationPeptide libraries: applications, design options and considerations. Laura Geuss, PhD May 5, 2015, 2:00-3:00 pm EST
Peptide libraries: applications, design options and considerations Laura Geuss, PhD May 5, 2015, 2:00-3:00 pm EST Overview 1 2 3 4 5 Introduction Peptide library basics Peptide library design considerations
More informationPlatelet Refractoriness: The Basics. Martin H. Bluth, MD, PhD
Platelet Refractoriness: The Basics Martin H. Bluth, MD, PhD Complete Toxicology Laboratories, LLC Objectives Define platelet refractoriness and associated conditions that may cause platelet refractoriness.
More informationBiomarkers, Early Prediction of Vaccine Efficacy and Safety
Biomarkers, Early Prediction of Vaccine Efficacy and Safety Giuseppe Pantaleo, M.D. Professor of Medicine Head, Division of Immunology and Allergy Executive Director, Swiss Vaccine Research Institute Lausanne
More informationImmunotherapy in myeloma
Immunotherapy in myeloma This Horizons Infosheet contains information on immunotherapy, a type of treatment being investigated in myeloma. The Horizons Infosheet series provides information relating to
More informationBiological immune systems
Immune Systems 1 Introduction 2 Biological immune systems Living organism must protect themselves from the attempt of other organisms to exploit their resources Some would-be exploiter (pathogen) is much
More informationIg Isotype (Human) Quantitative Antibody Array
Ig Isotype (Human) Quantitative Antibody Array Catalog Number AA0113 8 Samples/Slide Version: 02 Intended for research use only www.abnova.com Introduction and Background A. Overview The human immune system
More informationBiological Inventions
Note: When any ambiguity of interpretation is found in this provisional translation, the Annex B Japanese text shall prevail. Chapter 2 Biological Inventions In this chapter, the application of Examination
More informationMucosal Immunity induced by VLPs
Virus-like paticles (VLPs) as vaccines, vectors and adjuvants, Fondation Mérieux, Annecy, 04 Mucosal Immunity induced by VLPs Denise Nardelli-Haefliger Lausanne University Hospital, Switzerland Purified
More informationBasic Immunology Lecture 1 st and 2 nd
Basic Immunology Lecture 1 st and 2 nd Introduction Requirements of the Department. Historical overview. Composition of the immune system. Molecular components of the immune systemes Immunological recognition
More informationFORENSIC SEROLOGY. Chapter PRENTICE HALL 2008 Pearson Education, Inc. Upper Saddle River, NJ 07458
Chapter 8 FORENSIC SEROLOGY 8-1 Nature of Blood The word blood refers to a highly complex mixture of cells, enzymes, proteins, and inorganic substances. Plasma, which is the fluid portion of blood, is
More informationnot to be republished NCERT BIOTECHNOLOGY AND ITS APPLICATIONS CHAPTER BIOLOGY, EXEMPLAR PROBLEMS MULTIPLE-CHOICE QUESTIONS
82 BIOLOGY, EXEMPLAR PROBLEMS CHAPTER 12 BIOTECHNOLOGY AND ITS APPLICATIONS 1. Bt cotton is not: a. A GM plant b. Insect resistant MULTIPLE-CHOICE QUESTIONS c. A bacterial gene expressing system d. Resistant
More informationPREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland Approved for public release; distribution unlimited
AD Award Number: W81XWH-7-1-345 TITLE: Second-Generation Therapeutic DNA Lymphoma Vaccines PRINCIPAL INVESTIGATOR: Larry W. Kwak, MD, PhD CONTRACTING ORGANIZATION: The University of Texas M. D. Anderson
More informationSee more signal with less noise
See more signal with less noise SeraCare KPL Antibodies & Conjugates See more signal with less noise In nature many animals use camouflage to escape detection. An animal s survival often depends upon its
More informationSupplementary Figure 1. Utilization of publicly available antibodies in different applications.
Supplementary Figure 1 Utilization of publicly available antibodies in different applications. The fraction of publicly available antibodies toward human protein targets is shown with data for the following
More informationVeins Valves prevent engorgement and backflow. Baroreceptor reflex. Veins returning blood
Veins have large radii and low resistance. Walls are thin, not elastic Most blood volume is in veins Veins returning blood Veins Valves prevent engorgement and backflow Sympathetic NS constricts veins
More informationApplications of HTRF and Tag-lite Assays for HTP Antibody Screening
Applications of HTRF and Tag-lite Assays for HTP Antibody Screening Brigitte Devaux, PhD Bristol Myers Squibb, Redwood City CA HTRF Symposium April 25, 2013 1 Introduction Generate human therapeutic antibodies
More informationIMMUNOBIOLOGY : AN INTRODUCTION
Immunobiology : An Introduction MODULE - 5 30 IMMUNO : AN INTRODUCTION We all get infections, but some of us fall sick more frequently than others. This is related to the immune system. Proper functioning
More informationELISA IMMUNOASSAY FOR HUMAN
Unit 6/ Module 1 /Version A pg. 1 California Lutheran University s Enriched Science (Clues) and California State University Program for Education and Research in Biotechnology (C-SUPERB) ELISA IMMUNOASSAY
More informationName_BS50 Exam 3 Key (Fall 2005) Page 2 of 5
Name_BS50 Exam 3 Key (Fall 2005) Page 2 of 5 Question 1. (14 points) Several Hfr strains derived from the same F + strain were crossed separately to an F - strain, giving the results indicated in the table
More informationNature Immunology: doi: /ni Supplementary Figure 1
Supplementary Figure 1 BALB/c LYVE1-deficient mice exhibited reduced lymphatic trafficking of all DC subsets after oxazolone-induced sensitization. (a) Schematic overview of the mouse skin oxazolone contact
More informationGeneration of Recombinant Antibodies and Means for Increasing Their Affinity
ISSN 0006-2979, Biochemistry (Moscow), 2010, Vol. 75, No. 13, pp. 1584-1605. Pleiades Publishing, Ltd., 2010. Original Russian Text E. P. Altshuler, D. V. Serebryanaya, A. G. Katrukha, 2010, published
More information